BRITTANY ZARRELLA: Open Payments
NPI 1710651005 · MIDDLEBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 90 payments from 21 companies in 2025. Trend: 2023 $1,563 · 2024 $1,874 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $665 |
| ARGENX US, INC. | 6 | $193 |
| SK Life Science, Inc. | 9 | $166 |
| MDD US Operations, LLC | 2 | $142 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Supernus Pharmaceuticals, Inc. | 1 | $83 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $42 |
| Celgene Corporation | 2 | $41 |
| Tanabe Pharma America, Inc. | 2 | $36 |
Products named: QULIPTA, UBRELVY, VYVGART HYTRULO, Gocovri, VYALEV, REXULTI, Qelbree, Symbravo.
Industry payments across CT — which companies pay providers there.
